Enanta Pharmaceuticals, Inc. (ENTA) vs Ocugen, Inc. (OCGN)
Enanta Pharmaceuticals, Inc. and Ocugen, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Ocugen, Inc. are of similar size ($349.5M and $339.1M). Enanta Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 0.70% against −3.66%. Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −1,786.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Enanta Pharmaceuticals, Inc. leads on 11 and Ocugen, Inc. on 3.
Valuation
Profitability
| Metric | ENTA | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (89.99%) | (1,504.43%) | 0.00% |
| Net margin | (96.89%) | (1,786.27%) | 0.00% |
| Free cash flow margin | (56.60%) | (1,332.36%) | 0.00% |
| Return on equity | (70.12%) | 1,211.66% | (57.72%) |
| Return on assets | (21.15%) | (92.03%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack